Use of multiple antigens stimulating cellular therapy to treat patients with hepatocellular carcinoma.

被引：0
|
作者：
Han, Yanyan [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Infect Dis & Hepatol Unit, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e14530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14530
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Multiple antigens stimulating cellular therapy increases immune responses in patients with hepatocellular carcinoma
    Han, Yanyan
    Huang, Jing
    Tao, Ran
    Guo, Yabing
    Liu, Li
    Wu, Dongyun
    Li, Jin
    Zhou, Xiangjun
    Hou, Jinlin
    [J]. CANCER RESEARCH, 2016, 76
  • [2] Supplement use in patients with hepatocellular carcinoma.
    Lee, Valerie
    Goyal, Abhishek
    Hsu, Christine Cho-Shing
    Rodriguez, Rosa D.
    Siegel, Abby B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Antigens recognized by autologous antibody in patients with hepatocellular carcinoma.
    Uemura, M
    Nouso, K
    Kobayashi, Y
    Tanaka, H
    Nakatsukasa, H
    Taniyama, M
    Fujikawa, T
    Matsumoto, E
    Fujiwara, K
    Nakamura, S
    Higashi, T
    Tsuji, T
    [J]. HEPATOLOGY, 2001, 34 (04) : 176A - 176A
  • [4] Gene therapy of hepatocellular carcinoma.
    王学浩
    李国强
    [J]. 中华肝脏病杂志, 2004, (11) : 56 - 57
  • [5] Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study
    He, Yajing
    Guo, Yabing
    Chen, Jinzhang
    Hu, Xiaoyun
    Li, Xiaoshuang
    Kong, Yanjun
    Zhang, Xiaoyong
    Zhou, Xiangjun
    Liu, Li
    Hou, Jinlin
    [J]. JOURNAL OF CANCER, 2018, 9 (08): : 1385 - 1393
  • [6] Sandostatin therapy for advanced hepatocellular carcinoma.
    Stadheim, LM
    Nzeako, UC
    Hassoun, Z
    LaRusso, NF
    Menon, KVN
    Roberts, LR
    Gores, GJ
    [J]. HEPATOLOGY, 2002, 36 (04) : 684A - 684A
  • [7] First US report on the use of proton beam therapy for hepatocellular carcinoma.
    Hillebrand, DJ
    Bush, DA
    Runyon, BA
    Cao, S
    Ojogho, O
    Chen, CS
    Slater, JD
    Slater, JM
    [J]. HEPATOLOGY, 1999, 30 (04) : 273A - 273A
  • [8] Multiple primary malignant tumors in patients with hepatocellular carcinoma. A review of 29 patients
    Manzini, VD
    Calucci, F
    Terpin, MM
    Loru, F
    Brollo, A
    Ramani, L
    Zuch, C
    Bianchi, C
    [J]. TUMORI, 1996, 82 (03) : 245 - 248
  • [9] Novel systemic therapies in hard to treat fibrolamellar hepatocellular carcinoma.
    Gliksberg, Ariel
    O'Grady, Claire
    Kent, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Cytotoxic T cell response to melanoma associated antigens (MAGE) in patients with hepatocellular carcinoma.
    Zerbini, A
    Pilli, M
    Orlandini, A
    Mori, C
    Soliani, P
    Pelosi, G
    Pedretti, G
    Penna, A
    Missale, G
    [J]. HEPATOLOGY, 2001, 34 (04) : 178A - 178A
12345